Intestinal Permeability Barrier in Crohn’s Disease: The Difficulty in Shifting the Paradigm
- Daniel Hollander
- … show all 1 hide
Crohn’s disease has become a relatively common inflammatory disease of the intestine. The etiology of the disease is unknown despite a great deal of research by many talented investigators. During most of the twentieth century, the search for Crohn’s etiology focused mostly on immunological abnormalities. This dominant paradigm hindered the approval of research proposals or manuscripts dealing with other, non-immunological etiological factors or mechanisms.
In the early 1980s my research centered on the intestinal transport of lipid compounds, in general, and fat-soluble vitamins in particular . Simultaneously, I was caring for increasing numbers of patients with Crohn’s disease and felt frustrated by the dearth of basic understanding of the etiology of Crohn’s disease and the paucity of available therapeutic approaches. It was known that the disease had a heritable component since it had a clear familial clustering, but the specific genetic abnormalities or predi ...
- Hollander D. Intestinal absorption of vitamins A, E, D and K. J Lab Clin Med. 1981;97:449–462.
- The Goldsmith Family Foundation. Los Angeles, CA.
- Pearson AD, Eastman EJ, Laker MF, Craft AW, Nelson R. Intestinal permeability in children with Crohn’s disease and celiac disease. Br Med J. 1982;285:20–21. CrossRef
- Bjarnason I, O’Morain C, Levi AJ, Peters TJ. Absorption of 51-Chromium-labeled ethylenediaminetetracetate in inflammatory bowel disease. Gastroenterology. 1983;85:318–322.
- Ukabam SO, Clamp JR, Cooper BT. Abnormal small intestinal permeability to sugars in patients with Crohn’s disease of the terminal ileum and colon. Digestion. 1983;27:70–74. CrossRef
- Delahunty T, Hollander D. Liquid chromatographic method for estimating urinary sugars: applicability to studies of intestinal permeability. Clin Chem. 1986;32:1542–1544.
- Hollander D, Vadheim CM, Brettholz E, Peterson GM, Delahunty TJ, Rotter JI. Increased intestinal permeability in Crohn’s patients and their relatives: an etiological factor. Ann Int Med. 1986;105:883–885. CrossRef
- Buhner S, Buning C, Genschel J, et al. Genetic basis for increased intestinal permeability in families with Crohn’s disease: role of CARD 15 3020insC mutation? Gut. 2006;55:342–347. CrossRef
- Teshima CW, Dieleman LA, Meddings JB. Abnormal intestinal permeability in Crohn’s disease pathogenesis. Ann N Y Acad Sci. 2012;1258:159–165. CrossRef
- Irvine EJ, Marshall JK. Increased intestinal permeability precedes the onset of Crohn’s disease in a subject with familial risk. Gastroenterology. 2000;119:1740–1744. CrossRef
- D’Inca R, Annese V, di Leo V, et al. Increased intestinal permeability and NOD2 variants in familial and sporadic Crohn’s disease. Aliment Pharmocol Ther. 2006;23:1455–1461. CrossRef
- Suenaert P, Bulteel V, Lemmens L, et al. Anti-tumor necrosis factor treatment restores the gut barrier in Crohn’s disease. Am J Gastroenterol. 2002;97:2000–2004. CrossRef
- Suzuki T. Regulation of intestinal epithelial permeability by tight junctions. Cell Mol Life Sci. 2013;70:631–659. CrossRef
- Intestinal Permeability Barrier in Crohn’s Disease: The Difficulty in Shifting the Paradigm
Digestive Diseases and Sciences
Volume 58, Issue 7 , pp 1827-1829
- Cover Date
- Print ISSN
- Online ISSN
- Springer US
- Additional Links
- Industry Sectors
- Daniel Hollander (1)
- Author Affiliations
- 1. Division of Digestive Diseases, UCLA School of Medicine and The Broad Foundation, 10900 Wilshire Blvd, 12th floor, Los Angeles, CA, 90024, USA